Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pheochromocytoma × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Carcinoma, Renal Cell 145 Kidney Neoplasms 42 Neoplasms 39 Neoplasm Metastasis 35 Breast Neoplasms 33 Gastrointestinal Stromal Tumors 31 Carcinoma, Non-Small-Cell Lung 22 Prostatic Neoplasms 16 Urinary Bladder Neoplasms 13 Colorectal Neoplasms 12 Brain Neoplasms 12 Pancreatic Neoplasms 11 Glioblastoma 11 Carcinoma, Hepatocellular 11 Melanoma 10 Lung Neoplasms 10 Carcinoma 10 Stomach Neoplasms 8 Neuroendocrine Tumors 8 Thyroid Neoplasms 7 Sarcoma 7 Ovarian Neoplasms 7 Multiple Myeloma 7 Liver Neoplasms 7 Adenoma, Islet Cell 7 Small Cell Lung Carcinoma 6 Leukemia, Myeloid, Acute 6 Glioma 6 Esophageal Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6

Interventions

3-Iodobenzylguanidine 14 Temozolomide 6 lutetium Lu 177 dotatate 5 gallium Ga 68 dotatate 4 anlotinib 4 Specimen Handling 4 Everolimus 4 Radiotherapy 3 Phenoxybenzamine 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 6-fluorodopamine 3 3-fluorobenzylguanidine 3 pegfilgrastim 2 olaparib 2 fluorodopa F 18 2 cabozantinib 2 belzutifan 2 Nivolumab 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Fluorodeoxyglucose F18 2 Filgrastim 2 Doxazosin 2 Dexmedetomidine 2 Capecitabine 2 Biopsy 2 Axitinib 2 Adrenalectomy 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00843037 2024-10-17

SNIPP

University Health Network, Toronto

Phase 2 Completed

25 enrolled 19 charts

Neoplasm Metastasis, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡